Table 4. Association of clinical characteristics and lipoproteins features in subjects with type 1 diabetes (T1D).
| Clinical variables R | Gender (+ for women) | BMI (kg/m2) | Abdominal fat % (DXA) | Total fat % (DXA) | VO2peak (mL/kg/min) |
|---|---|---|---|---|---|
| LipoProfile | |||||
| Large LDL-P | - | - | - | 0.505 | -0.520 |
| Large HDL-P | - | -0.627 | - | - | - |
| HDL size | 0.601 | - | - | - | - |
| PLS regression | |||||
| Total LDL-C | - | - | 0.502 | - | - |
| Small LDL-C | - | - | 0.552 | - | - |
| Large HDL-TG | 0.534 | - | - | - | - |
| Small HDL-TG | -0.586 | - | - | - | - |
| Conventional | |||||
| HDL-C | - | -0.564 | - | - | - |
Summary of the main clinical variables and lipoprotein features that reached R ≥ ± 0.5 and p value < 0.005. Other clinical variables did not reach R ≥ ± 0.5: age, physically active profile, METs, active smoking, HbA1c or eGDR.